BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Operating Income
BRAIN Biotech AG
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Operating Income
-€5.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Operating Income
€364.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
Evonik Industries AG
XETRA:EVK
|
Operating Income
€1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Covestro AG
XETRA:1COV
|
Operating Income
€153m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Operating Income
€57.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Operating Income
€550.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
See Also
What is BRAIN Biotech AG's Operating Income?
Operating Income
-5.7m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Operating Income amounts to -5.7m EUR.
What is BRAIN Biotech AG's Operating Income growth rate?
Operating Income CAGR 5Y
11%
Over the last year, the Operating Income growth was -7%. The average annual Operating Income growth rates for BRAIN Biotech AG have been 16% over the past three years , 11% over the past five years .